Welcome to our dedicated page for Itron SEC filings (Ticker: ITRI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Itron, Inc. (NASDAQ: ITRI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Itron is incorporated in Washington and reports under Commission File Number 000-22418. Through these filings, investors can review details about Itron’s intelligent infrastructure business for energy, water and city services, along with its financial condition and material corporate events.
Key documents for ITRI include current reports on Form 8-K, which disclose material events such as agreements to acquire software and services companies serving utilities, approval of share repurchase programs, entry into credit agreements and the release of quarterly financial results. These filings also cover board appointments and other governance matters. Annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) provide broader context on Itron’s Device Solutions, Networked Solutions and Outcomes segments, as well as risk factors and segment information.
On Stock Titan, Itron filings are updated in near real time as they appear in the SEC’s EDGAR system. AI-powered summaries help explain the significance of lengthy documents, highlighting items such as new credit facilities, acquisition agreements, share repurchase authorizations and results of operations. Users can quickly see which filings relate to capital structure, financing arrangements or strategic transactions.
For those tracking insider and governance activity, this page also serves as a gateway to Form 4 insider transaction reports and proxy-related disclosures when they are filed. Together, these documents give a structured view of how Itron manages its capital, executes acquisitions and reports on its intelligent infrastructure business to regulators and shareholders.
Itron, Inc. director Sheri Savage received a stock grant of 580 shares of Common Stock as part of her quarterly board compensation. The shares were awarded at no cash cost to her and are classified as a grant or other acquisition. Following this grant, she directly holds 1,766 shares of Itron common stock.
Perez Santiago reported acquisition or exercise transactions in this Form 4 filing.
ITRON, INC. director Perez Santiago received a grant of 580 shares of common stock on April 1, 2026. This award is part of the quarterly stock compensation that independent board members receive for their service. After this grant, Perez Santiago directly owns 11,898 shares of Itron common stock.
Mirchandani Sanjay reported acquisition or exercise transactions in this Form 4 filing.
Itron, Inc. director Sanjay Mirchandani received a stock grant of 580 shares of common stock as part of his quarterly board compensation. This grant was awarded at no cash cost per share and increased his direct holdings to 6,203 common shares following the transaction.
LEYDEN TIMOTHY M reported acquisition or exercise transactions in this Form 4 filing.
Itron, Inc. director Timothy M. Leyden received a grant of 232 shares of common stock as part of the quarterly compensation that independent board members receive. The award was at no cash cost per share and increased his direct holdings to 16,005 shares.
According to the disclosure, Leyden deferred receipt of 87 of these shares under Itron's Executive Deferred Compensation Plan, so only part of the award was taken immediately in stock while the remainder was deferred.
Lande Jerome J. reported acquisition or exercise transactions in this Form 4 filing.
ITRON, INC. director Jerome J. Lande received a grant of 580 shares of common stock on April 1, 2026 as part of the quarterly equity compensation paid to independent members of the board for their annual board service. Following this award, he directly holds 10,144 common shares.
JAEHNERT FRANK M reported acquisition or exercise transactions in this Form 4 filing.
Itron, Inc. director Frank M. Jaehnert received a grant of 580 shares of common stock as part of his board compensation. The award was made at a stated price of $0.00 per share, reflecting a non-cash stock grant rather than an open-market purchase. Following this grant, he directly holds 22,497 shares of Itron common stock. According to the disclosure, Mr. Jaehnert deferred receipt of these shares under Itron's Executive Deferred Compensation Plan, making this a routine, compensation-related equity award for an independent board member.
Drury Scott D. reported acquisition or exercise transactions in this Form 4 filing.
Itron, Inc. director Scott D. Drury received a grant of 580 shares of Common Stock as part of his quarterly board compensation. The shares were awarded at no cash cost per share and are tied to his service as an independent board member. Following this grant, his direct holdings increased to 1,723 shares of Itron common stock. According to the disclosure, Drury deferred receipt of these shares under Itron's Executive Deferred Compensation Plan, so the award will be delivered on a deferred basis rather than immediately.
Itron Inc ownership filing: The Vanguard Group amended its Schedule 13G to report zero beneficial ownership of Itron common stock. The filing states that, after an internal realignment effective January 12, 2026, certain Vanguard subsidiaries will report ownership separately in reliance on SEC Release No. 34-39538. The amendment certifies 0 shares and 0% beneficial ownership, and explains that Vanguard no longer is deemed to beneficially own shares held by those subsidiaries. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Itron, Inc. is asking shareholders to vote at its virtual 2026 annual meeting on May 7, 2026. Owners of its 44,319,803 common shares as of March 3, 2026 can attend online, vote and submit questions using a 16‑digit control number.
Shareholders will elect five directors, approve on a non‑binding basis 2025 compensation for named executive officers, and ratify Deloitte & Touche LLP as independent auditor for 2026. Directors are mostly independent, follow term limits and retirement guidelines, and are chosen for leadership, financial, industry, technology and global expertise.
The proxy details a pay‑for‑performance program centered on base salary, an annual cash bonus tied mainly to Adjusted EBITDA, revenue and strategic goals, and long‑term equity awards through performance‑based and time‑vested stock units. In 2025, Itron reported record profitability metrics, increased buyback capacity after repurchasing $100 million of shares, and completed or agreed to acquisitions that expand its intelligent infrastructure and AI‑enabled solutions portfolio.